Partnerships
Engaging in a value-driven partnership with Sciensus means you’ll be working with more than 1,800 professionals who genuinely understand your challenges, your ambitions and how to achieve them.
Why choose Sciensus
We are a European life sciences company specialising in market-leading patient access, engagement and insight solutions. With a presence across Europe, we sit proudly at the intersection of patients and their medicine, specifically those with chronic and long-term conditions, rare diseases and cancer.
Last year by numbers
We’ve come a long way since our story started back in 1992. Over three decades later, we’re proud of all we’ve achieved, including the following figures from 2022.
0.00 million
Deliveries
0
New patients registered
0
Patient visits
0
Medication orders compounded
Sciensus for pharma and biotech companies
Powered by 70 million patient interactions, we support pharma companies across the entire drug lifecycle, from pre-approval programs and access to influential prescribers to ongoing real-world data collection and insight-led patient engagement.
Sciensus for the NHS
We have been working with the NHS for 30 years, and now partner with almost 200 NHS organisations across the UK. The end-to-end service we provide helps thousands of patients with both simple and complex health conditions manage their treatments and live their lives to the fullest.
Sciensus for healthcare professionals
With coverage across the UK, our expert team delivers a high level of patient-centric care across more than 50 therapy areas, providing timely clinical assessments after every visit.
Decades of experience
International network
Clinical expertise
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.
Events
ASCO 2025
Sciensus will be attending the upcoming ASCO (American Society of Clinical Oncology). ASCO is one of the most influential events…
News
Sciensus achieves 95% patient satisfaction and record NPS
At Sciensus, delivering life-changing therapies is more than a service — it’s a commitment to the people behind every prescription.…
Blogs
Driving reimbursement success in Europe with real-world data
Andrew Cummins, Vice President Business Development, and Mathieu Loiseau, Director of Rare Clinical Services, spoke at the recent World Orphan…